The role of NMDA receptors in the slow neuronal degeneration of Parkinson's disease

Amino Acids

Volumn 14, Issue 1-3, 1998, Pages 17-23

  Loopuijt, L D ^a   Schmidt, W J ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Chronic neuronal degeneration; Excitotoxicity; Nigrostriatal neurons; NMDA receptors; Parkinson's disease

Indexed keywords

CALCIUM BINDING PROTEIN; CALCIUM ION; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; POSTSYNAPTIC RECEPTOR;

ALZHEIMER DISEASE; CALCIUM CELL LEVEL; CELL PROTECTION; CONFERENCE PAPER; CYTOSKELETON; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; HUMAN; HUMAN CELL; NERVE CELL DEGENERATION; NERVE CELL STIMULATION; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; PRIORITY JOURNAL; SENSORY NERVE; SUBSTANTIA NIGRA;

ALZHEIMER DISEASE; GLUTAMATES; HUMANS; NEURONS; PARKINSON DISEASE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0031975509     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01345237     Document Type: Conference Paper

References (41)

1. Agid Y (1991) Parkinson's disease: pathophysiology. Lancet 337: 1321-1324
2. Albin RL, Makowiec RL, Holingsworth ZR, Dure IVLS, Penney JB, Young AB (1992) Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiographic study. Neurosci 46: 35-48
3. Anglade P, Vyas S, Javoy-Agid F, Herrera MT, Michel PP, Marquez J, Mouatt-Prigent A, Ruberg M, Hirsch EC, Agid Y (1997) Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Pathol 12: 25-31
4. Beal MF (1992) Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol 31: 119-130
5. Bethlem J, Den Hartog Jager WA (1960) The incidence and charateristics of Lewy bodies in idiopathic paralysis agitans (Parkinson's disease). J Neurol Neurosurg Psychiatry 23: 74-80
6. Bevan MD, Bolam JP, Crossman AR (1994) Convergent synaptic input from the neostriatum and the subthalamus onto identified nigrothalamic neurons in the rat. Eur J Neurosci 6: 320-334
7. Braak E, Braak H, Mandelkow EM (1994a) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87: 554-567
8. Braak H, Braak E, Yilmazer D, de Vos RAI, Jansen ENH, Bohl J, Jellinger K (1994b) Amygdala pathology in Parkinson's disease. Acta Neuropathol 88: 493-500
9. Braak H, Braak E, Yilmazer D, de Vos RAI, Jansen ENH, Bohl J (1996) Pattern of brain destruction in Parkinson's and Alzheimer's diseases. J Neural Transm 103: 455-490
10. Choi DW (1992) Excitotoxic cell death. Neurobiology 23: 1261-1276
11. Christoffersen CL, Meltzer CT (1995) Evidence for N-methyl-D-aspartate and AMPA subtypes of the glutamate receptor on substantia nigra dopamine neurons: possible preferential role for N-methyl-D-aspartate receptors. Neurosci 67: 373-381
12. Galloway PG, Grundke-Iqbal I, Iqbal K, Perry G (1988) Lewy bodies contain epitopes both shared and distinct from Alzheimer neurofibrillary tangles. J Neuropathol Exp Neurol 47: 654-663
13. Gerfen CR, Herkenham M, Thibault J (1987a) The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. J Neurosci 7: 3915-3934
14. Gerfen CR, Baimbridge KG, Thibault J (1987b) The neostriatal mosaic: III. Biochemical and developmental dissociation of patch-matrix mesostriatal systems. J Neurosci 7: 3935-3944
15. German AM, McGowan A, O'Neill C, Cotter T (1996) Oxidative stress and apoptosis in neurodegeneration. J Neurol Sci 139 [Suppl]: 45-52
16. Gibb WRG (1988) The neuropathology of Parkinsonian disorders. In: Jankovic J, Toloa E (eds) Parkinson's disease and movement disorders. Urban and Schwarzenberg, Baltimore Munich, pp 205-223
17. Gibb WRG, Lees AJ (1991) Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J Neurol Neurosurg Psychiatry 54: 388-396
18. Goedert M (1993) Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci 16: 460-465
19. Goldman JE, Yen S-H, Chiu F-C, Peress NS (1983) Lewy bodies of Parkinson's disease contain neurofilament antigens. Science 221: 1082-1084
20. Greene JG, Greenamyre JT (1995a) Characterization of the excitotoxic potential of the reversible succinate dehydrogenase inhibitor malonate. J Neurochem 64: 430-436
21. Greene JG, Greenamyre JT (1995b) Exacerbation of NMDA, AMPA and L-glutamate excitotoxicity by the succinate dehydrogenase inhibitor malonate. J Neurochem 64: 2332-2338
22. Hammond C, Deniau JM, Rizk A, Feyer J (1978) Electrophysiological demonstration of an excitatory subthalamonigral pathway in the rat. Brain Res 151: 235-244
23. Hof PR, Morrison JH (1995) Neurofilament protein defines regional patterns of cortical organization in the Macaque monkey visual system: a quantitative immunohistochemical analysis. J Comp Neurol 352: 161-186
24. Hunter S (1985) The rostral mesencephalon in Parkinson's disease and Alzheimer's disease. Acta Neuropathol 68: 53-58
25. Huntley GW, Vicker JC, Morrison JH (1994) Cellular and synaptic localization of NMDA and non-NMDA receptor subunits in neocortex: organizational features related to cortical circuitry, function and disease. Trends Neurosci 17: 536-543
26. Iqbal K, Alonso AC, Gong CX, Khatoon S, Singh TJ, Grundke-Iqbal I (1994) Mechanism of neurofibrillary degeneration in Alzheimer's disease. Mol Neurobiol 9: 119-123
27. Kornhuber J, Kim J-S, Kornhuber M, Kornhuber HH (1984) The corticonigral projection: reduced glutamate content in the substantia nigra following frontal cortex ablation in the rat. Brain Res 322: 124-126
28. Kornhuber J, Weller M, Schoppenmeyer K, Riederer P (1994) Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties. J Neural Transm [Suppl] 43: 91-104
29. Lasek RJ, Oblinger MM, Drake PF (1983) The molecular biology of neuronal geometry: the expression of neurofilament genes influences axonal diameter. Cold Spring Harbor Symp Quant Biol 48: 731-744
30. Le W-D, Colom LV, Wie W, Smith G, Alexianu M, Appel SH (1995) Cell death induced by β-amyloid 1-40 in MES 23.5 hybrid clone: the role of nitric oxide and NMDA-gated channel activation leading to apoptosis. Brain Res 686: 49-60
31. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE (1992) Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicitity. J Neurosci 12: 376-389
32. Mercuri NB, Stratta F, Calabres P, Bernard G (1992) A voltage-clamp analysis of NMDAinduced responses on dopaminergic neurons of the rat substantia nigra zona compacta and ventral tegmental area. Brain Res 593: 51-56
33. Mitchell IJ, Lawson S, Moser B, Laidlaw SM, Cooper AJ, Walkinsaw G, Waters CM (1994) Glutamate-induced apoptosis results in a loss of striatal neurons in the Parkinsonian rat. Neurosci 63: 1-5
34. Naito A, Kita H (1994) The cortico-nigral projection in the rat: an anterograde tracing study with biotynilated dextran amine. Brain Res 637: 17-32
35. Nauta HJW, Cole M (1978) Efferent projections of the subthalamic nucleus: an autoradiographic study in monkey and cat. J Comp Neurol 180: 1-16
36. Qualman SJ, Haupt HM, Young P, Hamilton SR (1984) Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease. Gastroentrology 87: 848-856
37. Sonsalla PK, Nicklas WJ, Heikkila RE (1989) Role of excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science 243: 398-400
38. Sonsalla PK, Zeevalk GD, Manzino L, Giovanni A, Nicklas WJ (1992) MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats. J Neurochem 58: 1979-1982
39. Standaert DG, Testa CM, Young AB, Penney JB Jr (1994) Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat. J Comp Neurol 343: 1-16
40. + neurotoxicity by N-methyl-D-aspartate antagonists. Nature 349: 414-418
41. Youdim MBH, Ben-Sacher D, Riederer P (1994) The enigma of neuromelanin in Parkinson's disease substantia nigra. J Neural Transm [Suppl] 43: 113-122